INmune Bio, Inc.
NASDAQ:INMBBiotechnology
Healthcare
$1.89 +8.38%
+$0.15 today
- Market cap
- $50.25M
- Beta
- 0.98
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$1.56
52W Low $1.09High $3.24
Volume 0.09M
Average 0.68M
Price history
INmune Bio, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+26.85%
Period high
$2.51
Period low
$1.12
Latest
$1.89
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Sep 23, 2026 | Sep 23, 2026 | |
| 3 | Sep 23, 2026 | Sep 23, 2026 | |
| 4 | Sep 17, 2026 | Sep 17, 2026 | |
| 3 | Sep 16, 2026 | Sep 16, 2026 | |
| 8-K | Sep 14, 2026 | Sep 14, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Jul 31, 2026 | Jul 31, 2026 | |
| 4 | Jul 7, 2026 | Jul 7, 2026 | |
| 4 | Jul 7, 2026 | Jul 7, 2026 | |
| 4 | Jul 7, 2026 | Jul 7, 2026 | |
| 8-K | Jul 1, 2026 | Jul 1, 2026 | |
| 8-K | Jun 23, 2026 | Jun 23, 2026 | |
| 8-K | Jun 17, 2026 | Jun 17, 2026 | |
| 8-K | Jun 2, 2026 | Jun 2, 2026 | |
| 8-K | May 14, 2026 | May 14, 2026 |
Competitors
Who does INmune Bio, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about INMB's filings, answered from its disclosures.
What is the latest INMB filing?
The latest filing shown is 3 dated Sep 23, 2026.
How many recent filings does INMB have?
Intrinsic Alpha currently shows 20 recent filings for INMB.
Continue the stock analysis
Jump to another research area for this company.